Studies on new antibiotic lividomycins. VI. Absorption, excretion and tissue distribution of lividomycin A.
D000606:Amino Sugars / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000652:urine; D001646:Bile / Q000378:metabolism; D001923:Brain Chemistry; D002855:Chromatography, Thin Layer; D004285:Dogs; D006027:Glycosides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D007273:Injections, Intramuscular; D007294:Inositol / Q000378:metabolism; D007612:Kanamycin / Q000097:blood / Q000378:metabolism / Q000652:urine; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000378:metabolism
D000606:Amino Sugars; D000900:Anti-Bacterial Agents; D006027:Glycosides; D007294:Inositol; D007612:Kanamycin